Saturday, July 11, 2026

Drug profile · INN

iophendylate

iophendylate (PANTOPAQUE) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.

FDA: approved
US status approved
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — iophendylate
US status
approved
Class
Route
INJECTION
Patents
0
Programs
0
Data quality
0.84

Quick answer

iophendylate (PANTOPAQUE) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.

Key facts

INN iophendylate
Brand PANTOPAQUE
Route INJECTION
Formulation INJECTABLE

Approval history

Authority Status Date
FDA approved

Frequently asked questions

What is iophendylate?

iophendylate (PANTOPAQUE) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.

What is the brand name for iophendylate?

PANTOPAQUE is a marketed brand name for iophendylate. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of iophendylate?

iophendylate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.